CIK 0001585608
- Non-accelerated filer
- Smaller reporting company
Jaguar Health, Inc.
Sign in to watch- Ticker
- JAGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 415-371-8300
- Business address
- 200 PINE STREET SUITE 400, SAN FRANCISCO, CA, 94104
- Former names
- Jaguar Animal Health, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 83 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-18 | BOCHNOWSKI JAMES J Director | Grant or award · Restricted stock units | +39,400 | 39,400 | ||
| 2021-04-05 | Lizak Carol R. Chief Financial Officer | Grant or award · Stock option (right to buy) | +81,250 | 81,250 | ||
| 2021-04-05 | Lizak Carol R. Chief Financial Officer | Grant or award · Restricted stock units | +40,625 | 40,625 | ||
| 2018-09-25 | Nantucket Investments Ltd 10% owner | Sale | −325,615 | $1.83 | $596K | 0 |
| 2018-09-25 | Nantucket Investments Ltd 10% owner | Sale · Non-Voting Common Stock | +270,270 | $1.83 | $495K | 38,180,451 |
Page 10 of 10 · 185 trades